E-mail this story
Osiris shares rise on news of quarterly, annual profit
Columbia biotechnology company Osiris Therapeutics swung to a profit in the fourth quarter, and for all of 2013, sending its share price surging by as much as 10 percent Wednesday.
By Scott Dance, The Baltimore Sun
March 5, 2014